BMO's Elevated Valuation Tested by Skeptical Analyst; Master Report Cites Balanced Risks
Read source articleWhat happened
In a recent analysis, a Seeking Alpha contributor highlights Bank of Montreal's stock trading at an unprecedented 17x P/E, well above its historical 10-12x range, suggesting overvaluation. The article maintains a Hold rating with a CAD $140 fair value target, citing skepticism that the U.S.-centric growth story post-Bank of the West integration will sustain the premium multiple. DeepValue's latest master report also rates BMO as Hold/Neutral, acknowledging that the ~16.7x TTM P/E is not cheap but noting offsetting factors such as a newly approved NCIB and diversified fee engines. The master report flags key watch items including NIM trajectory, credit trends, and capital return execution that could shift the stance, while the article focuses squarely on valuation mean-reversion risk. Together, these views paint a picture of a bank with solid fundamentals but a price that already prices in optimistic outcomes, leaving little room for error if growth disappoints.
Implication
Investors should weigh BMO's diversified earnings and NCIB optionality against its elevated valuation. The stock offers a ~3.8% yield and potential for EPS growth if U.S. integration benefits materialize and credit remains benign. However, with P/E at the high end of its range, any negative surprise—such as persistent NIM compression or rising credit losses—could trigger multiple compression. The balanced view from DeepValue suggests maintaining positions but not adding aggressively. Look for a pullback to below 15x P/E or tangible evidence of sustained NIM improvement before increasing exposure.
Thesis delta
The new article reinforces the valuation risk element that was a secondary consideration in the master report. While the master report viewed the 16.7x P/E as reasonable, the article's historical context shifts the emphasis from 'balanced' to 'overvalued' relative to norms. This tilts the thesis toward a more defensive stance, awaiting either a lower entry price or clear catalyst for multiple expansion.
Confidence
Medium